AMAGAMAG Pharmaceuticals Inc


$ 13.76 $ 0.02 (0.15 %)    

Friday, 13-Nov-2020 15:59:27 EST
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 13.75
$ 13.75 x 2,800
$ 13.77 x 2,800
-- - --
$ 4.41 - $ 13.80
1,534,573
na
na
$ 1.49
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-daily-biotech-pulse-vertex-pulls-plug-on-protein-deficiency-drug-fda-nod-for-regenerons-ebola-treatment-can-fite-issues-psoriasis-readout

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 covis-group-s-rl-announces-commencement-of-tender-offer-for-all-outstanding-shares-of-amag-pharmaceuticals-inc

LUXEMBOURG and ZUG, Switzerland, Oct. 15, 2020 /CNW/ -- Covis Group S.à r.l. ("Covis") announced the commencement of a ...

 amag-pharma-reports-request-for-hearing-to-maintain-makena-as-treatment-option-for-clinically-indicated-pregnant-patients

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it has formally requested a public hearing in response to the U.S...

 the-daily-biotech-pulse-pfizer-biontech-begin-european-filing-for-coronavirus-vaccine-y-mabs-bla-rejected-glycomimetics-granted-rare-pediatric-disease-designation

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 amag-pharmaceuticals-provided-update-on-fdas-proposal-regarding-makena-says-15-days-to-respond-to-fda--continues-to-expect-its-recently-announced-tender-offer-and-merger-to-close-in-november-2020

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced that it received a notice from the U.S.

 amag-pharmaceuticals-shares-fall-sharply-lower-reuters-reports-fdas-center-for-drug-evaluation-and-research-proposes-withdrawal-of-approval-for-cos-makena

-Reuters

Core News & Articles

Upgrades

 10-biggest-price-target-changes-for-friday

Needham boosted Twilio Inc (NYSE: TWLO) price target from $310 to $320. Twilio shares rose 9% to $279.97 in pre-market trad...

 the-daily-biotech-pulse-mesoblast-slumps-on-fda-rejection-astrazenecas-breakthrough-therapy-designation-3-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 hc-wainwright--co-downgrades-amag-pharmaceuticals-to-neutral-lowers-price-target-to-1375

HC Wainwright & Co. analyst Douglas Tsao downgrades AMAG Pharmaceuticals (NASDAQ:AMAG) from Buy to Neutral and lowers th...

 51-biggest-movers-from-yesterday
51 Biggest Movers From Yesterday
10/02/2020 08:57:27

Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares climbed 70.4% to close at $3.46 on Thursday after the company announced...

 svb-leerink-maintains-market-perform-on-amag-pharmaceuticals-raises-price-target-to-1365

SVB Leerink analyst Ami Fadia maintains AMAG Pharmaceuticals (NASDAQ:AMAG) with a Market Perform and raises the price target...

Core News & Articles

Toward the end of trading Thursday, the Dow traded up 0.07% to 27801.83 while the NASDAQ rose 1.34% to 11,318. The S&P also...

Core News & Articles

Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares jumped 105% to $4.18 after the company announced the FDA has lifted the...

 piper-sandler-upgrades-amag-pharmaceuticals-to-neutral

Piper Sandler analyst Christopher Raymond upgrades AMAG Pharmaceuticals (NASDAQ:AMAG) from Underweight to Neutral.

 covic-group-announces-agreement-to-acquire-amag-pharmaceuticals-at-1375-per-share-in-cash-647m

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals Addition of AMAG's category leading treatments positions C...

 roce-insights-for-amag-pharmaceuticals

In Q2, AMAG Pharmaceuticals (NASDAQ: AMAG) posted sales of $52.76 million. Earnings were up 9.59%, but AMAG Pharmaceuticals sti...